SS-31
Elamipretide
A mitochondria-targeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane, studied for effects on mitochondrial cristae structure, ATP production, and oxidative stress. Evaluated in multiple clinical trials.
Half-life
~2 h, subcutaneous or IV. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Lyophilized powder kept frozen or refrigerated and protected from light; reconstituted solutions refrigerated, used within a limited window.
References
- Elamipretide review (PMC11816484)
- MMPOWER-3 / TAZPOWER trials
Related in Cognitive / Longevity
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.